Does Zepbound Work for People Without Diabetes?
Yes, Zepbound is specifically approved for weight management in adults without diabetes. The FDA approved tirzepatide (Zepbound) in November 2023 exclusively for chronic weight management in adults with obesity or overweight conditions, not for diabetes treatment. Clinical trials showed participants lost an average of 15-20% of their body weight over 72 weeks. Zepbound works by mimicking hormones that regulate blood sugar and slow gastric emptying, leading to reduced appetite and increased satiety. Unlike Mounjaro (the same drug approved for diabetes), Zepbound is prescribed at different dosing schedules optimized for weight loss rather than blood sugar control.
Related Questions
How much weight can you lose on Zepbound?
What are the side effects of Zepbound?
Who is eligible for Zepbound prescription?
Related Articles
Zepbound vs Mounjaro: Key Differences Explained
Learn how these two versions of tirzepatide differ in dosing, approval, and intended use. This guide breaks down which medication might be right for your specific health goals.
Complete Guide to GLP-1 Weight Loss Medications
Explore all FDA-approved GLP-1 receptor agonists for weight management, including effectiveness rates and eligibility criteria. Compare options like Zepbound, Wegovy, and Saxenda.
What to Expect During Your First Month on Zepbound
Understand the typical timeline for Zepbound results, common side effects, and practical tips for managing your treatment. Includes guidance on dosing escalation and lifestyle adjustments.